← All trials
NCT05570110
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 23, 2022
- Primary completion
- Mar 31, 2025
- Completion date
- Mar 31, 2025
- First posted
- Oct 6, 2022
- Last posted
- Oct 6, 2022
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Philipps University of MarburgLead sponsor
- Slovak Academy of SciencesCollaborator
- Philipps University of MarburgReponsible party - principal investigator
- Philipps University of MarburgStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.